Sound Shore Management’s investor letter for the second quarter of 2025 revealed returns of 3.06% for Investor Class and 3.10% for Institutional Class. The top five holdings for the fund in 2025 are also available for review. Teva Pharmaceutical Industries Limited saw a one-month return of 15.02% and shares gained 10.22% over the last 52 weeks, closing at $19.68 per share on September 9, 2025. In the investor letter, Sound Shore Management discussed Teva’s growth and strategic plan execution amidst regulatory uncertainties. Hedge funds reduced their holdings of Teva Pharmaceutical Industries Limited in the second quarter of 2025, despite a 1% revenue increase year-over-year to $4.2 billion. The company’s potential as an investment is acknowledged, but certain AI stocks are believed to offer greater upside potential with less downside risk.

Read more at Yahoo Finance: Here’s Why Sound Shore Fund Added Teva Pharmaceutical Industries Limited (TEVA) in Q2